BD&L Helpful Links
BD&L Home Agenda Join The Mailing List Group Registrations
FBW BDL Intro

Where Strategy, Partnerships, and Growth Meet

Gain the insights you need to source, structure, and close high-value deals. Learn from experts in licensing, M&A, venture capital, and strategic alliances to elevate your BD approach.

Register now and save — advanced rate available through August 29.

Beat the Deadline – Register Now

Deals That Drive Discovery:

BD&L Leaders on Stage

Featured Speakers

Anthony Jarkowski

Anthony Jarkowski

Vice President, Head of Search & Evaluation, Business Development

Bristol Myers Squibb
Jim Koers

Jim Koers

Associate Vice President, Head of Due Diligence

Eli Lilly and Company
Jimmy Zhuang

Jimmy Zhuang

Assistant General Council, Business Development

Novo Nordisk
Christopher Mortko

Christopher Mortko

Vice President, Head Search and Evaluation, Business Development & Licensing

Merck
Michael Palladinetti

Michael Palladinetti

Global Head of Immunology & Inflammation Business Development

Sanofi
Tom Hopkins

Tom Hopkins

Vice President, Head, ExploR&D

Eli Lily & Company
Linda Goodman

Linda Goodman

Co Founder

Fauna Bio
Dinesh Patel

Dinesh Patel

CEO

Protagonist Therapeutics
Nisha Zaidi

Nisha Zaidi

Vice President, Head of Global Alliances, Business Development

Bristol Myers Squibb
Jeremy Levin

Jeremy Levin

Chairman and CEO

Ovid Therapeutics
Meet the Speakers
Partnering for Success
Partnering for Success
Explore flexible partnership models, licensing deals, platform and non-asset deals, M&A opportunities, and build deal structures to maximize potential and profitable collaboration.
Deal Structuring
Deal Structuring
Examine the differences in valuation and alternative deal structures for creative financing.
Contract Negotiations
Contract Negotiations
Hear what it takes to draft and negotiate key contract terms to minimize future risk.
Due Diligence
Due Diligence
Gain insights on conducting a comprehensive and cost-effective due diligence assessment. 

Key Topics Covered for BD&L​ 

  Deal Drivers and Investment Priorities for Big Pharma and VCs

  Operating Models for Search and Evaluation to Advance Innovation

  IP Due Diligence Issues that can Derail a Deal 

  Dealmaking Trends and Insights for New Modalities and Technologies

  Alternative Deal Constructs and Creative Financing 

  Negotiating and Evaluating Platform Deals 

Be in the Room
BDL Topics